Search results
Added:
1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview…
View more
Added:
1 week ago
HRS 2026 – Dr Enrico Ferro (Beth Israel Deaconess Medical Center, Boston, MA) returns to discuss findings from a large single-centre comparative safety analysis of pulsed field ablation (PFA) versus radiofrequency (RF) ablation for atrial fibrillation, originally presented at EHRA 2026 in Paris as a Young Investigator Award submission.Conducted at one of the highest-volume PVI centres in the US,…
View more
Added:
2 weeks ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may…
View more
Added:
4 weeks ago
EHRA 2026 — Dr Jason Andrade (University of British Columbia, CA) joins us to explore how artificial intelligence is transforming risk prediction and modulation in arrhythmia management, and what this means for electrophysiology practice today and in the years ahead.From the limitations of conventional risk stratification tools to the emerging role of AI-driven models in clinical decision-making,…
View more
Added:
3 months ago
In this episode of Arrhythmia Academy's Journal Club, Dr David Duncker (Hannover Heart Rhythm Center, DE) is joined by Dr Marat Fudim (Duke University, US) to examine the critical early-risk period following heart failure diagnosis and the emerging role of wearable cardioverter defibrillators in sudden cardiac death prevention.The discussion centres on findings from the SCD-PROTECT study, a 19…
View more
Added:
7 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type…
View more
Overview of Genetic Risk Factors and Aetiologies
Added:
9 months ago
Review Article
Risk Stratification in Arrhythmogenic Mitral Valve Prolapse
Added:
1 year ago
Review Article
Added:
1 month ago
Source:
Arrhythmia Academy
Atrial fibrillation (AF), particularly when paroxysmal and asymptomatic, often goes undiagnosed, increasing the risk of stroke. A recent trial investigated whether remote screening with a commercially available smartwatch could enhance the detection of new-onset AF in an older population with an elevated risk of stroke.²Mechanism of ApplicationThe intervention utilised a smartwatch equipped with…
View more
Added:
2 months ago
Source:
Radcliffe CVRM
Renin-independent aldosteronism is a common and often underrecognised condition. A new analysis from the Atherosclerosis Risk in Communities (ARIC) study has investigated whether this broader spectrum of aldosteronism is associated with incident cardiovascular disease (CVD) in older, community-dwelling adults.¹MethodologyThis prospective cohort analysis included 3,477 participants from the ARIC…
View more